Upadacitinib improves clinical outcomes in patients with moderate to severely active crohn's disease irrespective of previous failure to respond to biologics or conventional therapies
GASTROENTEROLOGY(2023)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined